Chargement
Health & Life Sciences
| # | Company | Country | City | Revenue | Headcount | Fiscal year |
|---|---|---|---|---|---|---|
| 1 | АКЦИОНЕРНОЕ ОБЩЕСТВО "Р-ФАРМ" | 1.55 bn EUR | 2024 | |||
| 2 | COURBEVOIE | 999.2 M EUR | 2024 | |||
| 3 | Ballerup | 986.2 M EUR | 2016 | |||
| 4 | 925.5 M EUR | 2024 | ||||
| 5 | LYON | 690.6 M EUR | 2023 | |||
| 6 | Hillerød | 643.4 M EUR | 2025 | |||
| 7 | 632.5 M EUR | 2025 | ||||
| 8 | ANNECY | 599.4 M EUR | 2024 | |||
| 9 | CLERMONT-FERRAND | 516.4 M EUR | 2023 | |||
| 10 | NEUILLY-SUR-SEINE | 505 M EUR | 2024 |
The Drugs (pharmaceutical) sector belongs to the Health & Life Sciences group of the Argos taxonomy. It gathers 4,789 companies across 21 countries, assigned from the activity declared to the national registry. Pick a country for the full list, or export the European scope directly to Excel.
The table shows the top 10 European companies in the sector by revenue, in public access. Of the 4,789 companies in the sector, 2,540 publish revenue, for 41.5 bn EUR combined. The best covered countries are Russia (2,138), United Kingdom (1,223), France (333). The full list and the Excel export come with an account.